Home > Promising COVID Vaccine Sends Stocks Soaring

Business
Promising COVID Vaccine Sends Stocks Soaring

Description

On Monday, US stocks soared to record highs. This came after Pfizer said its COVID-19 vaccine showed more than 90% efficacy in its phase 3 trial that enrolled 44,000 patients. Business Insider reports that both the S&P 500 and Dow Jones industrial average opened at intraday all-time highs. The development could remove pandemic significant uncertainty from the market. Airlines, restaurants, and financial sectors soared. Work-from-home stocks like Zoom, Peloton, and Netflix plummeted.

Added on the 09/11/2020 10:31:39 - Copyright : Wochit

To customise your video :

Generic export code

More videos on the subject

Netflix Drops 9% After Vaccine News

On Monday, phrama giant Pfizer revealed positive COVID-19 vaccine news. The news sent shares of stay-at-home stocks like Netflix plummeting on Monday. Netflix itself fell as much as 9%, even as major indexes like the S&P 500 and Dow Jones industrial average soared to record highs. Consumers flocked to entertainment alternatives amid the lengthy stay-at-home orders. Netflix saw a spike in subscribers due to the COVID-19 pandemic.

09/11/2020 - Wochit
Dow Surges After Pfizer COVID-19 Vaccine More Than 90% Effective

09/11/2020 - Wochit
Thailand's COVID-19 vaccine trial on monkeys provide promising reults, reserchers say

Bangkok, Jun 22 (EFE/EPA).-Researchers from Thailand’s Chulalongkorn University on Monday held a press conference to update on the progress towards developing an mRNA-type vaccine against coronavirus infections, assuring the initial result of the trial on monkeys is promising and that they will proceed with human trial within this year.The research team in Thailand began running vaccine tests on monkeys on May 23 and second dose is given on June 22, after initial tests on mice proved to be effective. Thailand COVID-19 vaccine program is on track with the planned human trial later on in 2020, said professor Kiat Ruxrungtham, one of the researchers. (Camera: NARONG SANGANK).FOOTAGE SHOWS A PRESS CONFERENCE TO UPDATE ON THE PROGRESS TOWARDS DEVELOPING AN MRNA TYPE VACCINE AT THE NATIONAL PRIMATE RESEARCH CENTER OF THAILAND-CHULALONGKORN UNIVERSITY (NPRCT-CU) IN SARABURI PROVINCE, THAILAND.

22/06/2020 - EFE Inglés
Tokyo stocks briefly rise over 500 points on expectation for COVID-19 vaccine development

Tokyo, May 19 (EFE/EPA).- The Tokyo stock benchmark Nikkei briefly rose over 500 points during the trading on Tuesday due to expectation for vaccine development of the COVID-19 coronavirus, before ending at 20,433.45 points, up 299.72 points or 1.49 percent(Camera: KIMIMASA MAYAMA).FOOTAGE SHOWS PEDESTRIANS WALKING PAST A SCREEN SHOWING CLOSING INFORMATION OF TOKYO'S NIKKEI STOCK AVERAGE, WHILE THE JAPANESE CAPITAL IS STILL UNDER CORONAVIRUS STATE OF EMERGENCY, IN TOKYO, JAPAN.

19/05/2020 - EFE Inglés
Canada's Ontario to abandon Covid vaccine passport: premier

The premier of Ontario announces that he will lift vaccine passport requirements in the Canadian province, the epicenter of protests against Covid-19 health measures for more than two weeks now. SOUNDBITE

14/02/2022 - AFPTV - First images